Warning: The NCBI web site requires JavaScript to function. more...
Is low-nicotine Marlboro snus really snus?
Foulds J, Furberg H.
Harm Reduct J. 2008 Feb 27;5:9.
Related citations
New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I, Jensen J, Hatsukami D, Hecht SS.
Nicotine Tob Res. 2008 Dec;10(12):1773-82.
Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers.
Cobb CO, Weaver MF, Eissenberg T.
Tob Control. 2010 Oct;19(5):367-73. Epub 2009 Apr 2.
[Harm reduction strategy in tobacco control].
Gorini G.
Epidemiol Prev. 2011 May-Aug;35(3-4 Suppl 1):19-32. Review. Italian.
Increased Pouch Sizes and Resulting Changes in the Amounts of Nicotine and Tobacco-Specific N-Nitrosamines in Single Pouches of Camel Snus and Marlboro Snus.
Stepanov I, Jensen J, Biener L, Bliss RL, Hecht SS, Hatsukami DK.
Nicotine Tob Res. 2012 Jan 17. [Epub ahead of print]
Monitoring Tobacco-Specific N-Nitrosamines and Nicotine in Novel Marlboro and Camel Smokeless Tobacco Products: Findings From Round 1 of the New Product Watch.
Stepanov I, Biener L, Knezevich A, Nyman AL, Bliss R, Jensen J, Hecht SS, Hatsukami DK.
Nicotine Tob Res. 2011 Oct 29. [Epub ahead of print]
Reduction in nicotine intake and oral mucosal changes among users of Swedish oral moist snuff after switching to a low-nicotine product.
Andersson G, Axéll T, Curvall M.
J Oral Pathol Med. 1995 Jul;24(6):244-50.
Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
Hatsukami DK, Lemmonds C, Zhang Y, Murphy SE, Le C, Carmella SG, Hecht SS.
J Natl Cancer Inst. 2004 Jun 2;96(11):844-52.
Effect of smokeless tobacco (snus) on smoking and public health in Sweden.
Foulds J, Ramstrom L, Burke M, Fagerström K.
Tob Control. 2003 Dec;12(4):349-59. Review.
US smokers' reactions to a brief trial of oral nicotine products.
O'Connor RJ, Norton KJ, Bansal-Travers M, Mahoney MC, Cummings KM, Borland R.
Harm Reduct J. 2011 Jan 10;8(1):1.
Cigarettes with defective filters marketed for 40 years: what Philip Morris never told smokers.
Pauly JL, Mepani AB, Lesses JD, Cummings KM, Streck RJ.
Tob Control. 2002 Mar;11 Suppl 1:I51-61. Review.
Smokeless tobacco: a gateway to smoking or a way away from smoking.
Melikian AA, Hoffmann D.
Biomarkers. 2009 Jul;14 Suppl 1:85-9. Review.
Receptivity to Taboka and Camel Snus in a U.S. test market.
Biener L, Bogen K.
Nicotine Tob Res. 2009 Oct;11(10):1154-9. Epub 2009 Jun 29.
The Swedish snus and the Sudanese toombak: are they different?
Idris AM, Ibrahim SO, Vasstrand EN, Johannessen AC, Lillehaug JR, Magnusson B, Wallström M, Hirsch JM, Nilsen R.
Oral Oncol. 1998 Nov;34(6):558-66. Review.
What do Marlboro Lights smokers know about low-tar cigarettes?
Cummings KM, Hyland A, Bansal MA, Giovino GA.
Nicotine Tob Res. 2004 Dec;6 Suppl 3:S323-32.
Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
Andersson G, Björnberg G, Curvall M.
J Oral Pathol Med. 1994 Apr;23(4):161-7.
Should the European Union lift the ban on snus? Evidence from the Swedish experience.
Fagerström KO, Schildt EB.
Addiction. 2003 Sep;98(9):1191-5. Review.
Oral tobacco products: preference and effects among smokers.
Hatsukami DK, Jensen J, Anderson A, Broadbent B, Allen S, Zhang Y, Severson H.
Drug Alcohol Depend. 2011 Nov 1;118(2-3):230-6. Epub 2011 Apr 23.
The nicotine market: an attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countries.
Fagerström K.
Nicotine Tob Res. 2005 Jun;7(3):343-50.
Role of snus (oral moist snuff ) in smoking cessation and smoking reduction in Sweden.
Gilljam H, Galanti MR; Swedish Cancer Society; Pharmacia AB.
Addiction. 2003 Sep;98(9):1183-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on